Skip to content

Replimune Group REPL Income Statement

Q3 '26Q2 '26Q1 '26Q4 '25Q3 '25
$53.14M-8.2%$57.88M+0.1%$57.84M+7.2%$53.98M+12.4%$48M+10.5%
$18.73M-29.1%$26.41M-18.9%$32.58M+28.5%$25.35M+40.7%$18.02M+16.5%
$71.87M-14.7%$84.29M-6.8%$90.42M+14.0%$79.33M+20.2%$66.02M+12.1%
$71.87M-14.7%$84.29M-6.8%$90.42M+14.0%$79.33M+20.2%$66.02M+12.1%
-$71.87M+14.7%-$84.29M+6.8%-$90.42M-14.0%-$79.33M-20.2%-$66.02M-12.1%
$1.47M-1.5%$1.49M+0.9%$1.48M+1.0%$1.46M+0.8%$1.45M+0.8%
$2.85M-23.0%$3.7M-21.6%$4.71M-19.8%$5.88M+14.4%$5.14M-4.8%
$627K-47.4%$1.19M-68.1%$3.73M-26.8%$5.09M+1,904%$254K-95.7%
-$71.24M-$74.24M-12.9%-$65.77M-24.0%
-$311K$575K
-$70.93M+14.6%-$83.1M+4.1%-$86.69M-16.9%-$74.13M-11.7%-$66.34M-25.0%
-$0.77+14.4%-$0.90+5.3%-$0.95-15.9%-$0.82-3.8%-$0.79-16.2%
-$0.77+14.4%-$0.90+5.3%-$0.95-15.9%-$0.82-3.8%-$0.79-16.2%
92.2M+0.3%91.9M+0.4%91.5M+13.6%80.6M-3.5%83.5M+6.3%
92.2M+0.3%91.9M+0.4%91.5M+13.6%80.6M-3.5%83.5M+6.3%
$2.85M-23.0%$3.7M-21.6%$4.71M-19.8%$5.88M+14.4%$5.14M-4.8%
$1.47M-1.5%$1.49M+0.9%$1.48M+1.0%$1.46M+0.8%$1.45M+0.8%
-$580K+33.8%-$876K-248%$591K-$3.28M-262%
$341K-9.5%$377K-10.2%$420K-23.8%$551K+46.5%$376K-7.8%
-$71.87M+14.7%-$84.29M+6.8%-$90.42M-14.0%-$79.33M-20.2%-$66.02M-12.1%
-$71.07M+14.9%-$83.49M+6.8%-$89.55M-14.1%-$78.48M-20.7%-$65.02M-12.1%
-$71.07M+14.9%-$83.49M+6.8%-$89.55M-14.1%-$78.48M-20.7%-$65.02M-12.1%
-$71.87M+14.7%-$84.29M+6.8%-$90.42M-14.0%-$79.33M-20.2%-$66.02M-12.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Is Replimune Group profitable?
Replimune Group is not currently profitable: it reported a net loss of $314.9M over the trailing twelve months.
What is Replimune Group's earnings per share?
Replimune Group's diluted EPS over the trailing twelve months is $-3.44.
Where does Replimune Group's income statement data come from?
Every line is extracted from Replimune Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.